![Pyrido[2,3-d]pyrimidin-7(8H)-one,6-acetyl-8-cyclopentyl-5-methyl-2-[[5-(1-piperazinyl)-2-pyridinyl]amino]-,monohydrochloride](https://static.cymitquimica.com/cas-image/386981-pyrido-23-d-pyrimidin-7-8h-one-6-acetyl-8-cyclopentyl-5-methyl-2-5-1-piperazinyl-2-pyridinyl-amino-monohydrochloride.png)
CAS: 827022-32-2 - Pyrido[2,3-d]pyrimidin-7(8H)-one,6-acetyl-8-cyclopentyl-5-methyl-2-[[5-(1-piperazinyl)-2-pyridinyl]amino]-,monohydrochloride
Formula:C24H29N7O2・ClH
- Synonyms:
- Palbociclib HCl
- Palbociclib hydrochloride
![6-acetyl-8-cyclopentyl-5-methyl-2-[(5-piperazin-1-ylpyridin-2-yl)amino]pyrido[2,3-d]pyrimidin-7-one hydrochloride](https://static.cymitquimica.com/products/AN/thumb/AG00392X.jpg)
6-acetyl-8-cyclopentyl-5-methyl-2-[(5-piperazin-1-ylpyridin-2-yl)amino]pyrido[2,3-d]pyrimidin-7-one hydrochloride
CAS:827022-32-2
Formula:
C24H30ClN7O2
Purity:
98%
Color and Shape:
Solid
Molecular weight:
483.9937
Ref: AN-AG00392X
| 1g | 99.00 € | |
| 5g | 175.00 € | |
| 10g | 303.00 € | |
| 25g | 633.00 € | |
| 5mg | 34.00 € | |
| 10mg | 34.00 € | |
| 100mg | 54.00 € | |
| 250mg | 50.00 € |
Estimated delivery in United States, on Monday 13 May 2024
Ref: 10-F794120
| 5mg | 22.00 € | |
| 10mg | 34.00 € | |
| 50mg | 43.00 € | |
| 100mg | 52.00 € | |
| 200mg | 213.00 € | |
| 500mg | 365.00 € |
Estimated delivery in United States, on Tuesday 14 May 2024
Palbociclib monohydrochloride
CAS:827022-32-2
Palbociclib monohydrochloride (PD 0332991 hydrochloride) is a selective inhibitor of CDK4/6 (IC50s: 11/16 nM). It …
Formula:
C24H29N7O2·HCl
Purity:
100%
Color and Shape:
Solid
Molecular weight:
483.99
Ref: TM-T6239
| 5mg | 54.00 € | |
| 10mg | 68.00 € | |
| 50mg | 87.00 € | |
| 100mg | 108.00 € | |
| 200mg | 135.00 € |
Estimated delivery in United States, on Tuesday 21 May 2024
PD 0332991 hydrochloride
CAS:827022-32-2
Inhibitor of cyclin D kinases Cdk4 and Cdk6; antineoplastic
Formula:
C24H29N7O2·HCl
Purity:
Min. 95%
Molecular weight:
483.99 g/mol
Ref: 3D-FP137711
| 10mg | To inquire | |
| 50mg | To inquire |
Estimated delivery in United States, on Tuesday 25 Jun 2024
